Insider trades
Raju Prasad, CFO of Crispr Therapeutics CRSP, has filed 0 purchases and 13 sales on the open market. Over the past 12 months that comes to a net sale of $5.1M. The latest trade was on 05/29.
Raju Prasad
CFO
- Company
- Crispr Therapeutics CRSP
- First filing
- 23/03/14
- Trades
- 46 trades
- Buys / sales
- 0 / 13
- 12-month net buying
- −$5.1M
- Last trade
- 05/29
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 03/23 | 03/24 | 3,708 sh | $46.78 | $173,460.24 | −19.2% | |
CRSP | Open-market sale | 03/16 | 03/17 | 9,869 sh2 trades | $48.26avg. | $476,277.94 | −41.7% |
| Open-market sale10b5-1 plan | 01/22 | 01/26 | 34,972 sh | $60.19 | $2,104,964.68 | −83.8% | |
CRSP | Open-market sale10b5-1 plan | 01/06 | 01/08 | 29,700 sh3 trades | $60.16avg. | $1,786,618.17 | −81.4% |
CRSP | Open-market sale10b5-1 plan | 25/12/22 | 25/12/23 | 10,000 sh3 trades | $55.95avg. | $559,520.56 | −59.6% |
| Open-market sale | 25/03/21 | 25/03/24 | 2,197 sh | $41.23 | $90,582.31 | −11.6% | |
| Open-market sale | 25/03/17 | 25/03/18 | 3,762 sh | $41.80 | $157,251.6 | −22.8% | |
| Open-market sale | 24/03/15 | 24/03/18 | 3,524 sh | $72.69 | $256,159.56 | −35.2% |